News archive
Serotonin changes how people learn and respond to negative information – new study
12 August 2024
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature Communications.
Investigating the link between Alzheimer’s disease biomarkers and online testing for cognitive impairment
29 July 2024
A study into Alzheimer’s disease, completed by researchers in the BRC’s Dementia Theme, has found that data gathered from online cognition testing correlates to protein blood biomarker levels associated with the disease.
The DIME Study – Is a ketogenic diet beneficial for people with treatment-resistant depression?
29 July 2024
Researchers from the Biomedical Research Centre’s Preventing Multiple Morbidities Theme are looking into whether a ketogenic diet is an effective treatment for treatment-resistant depression (TRD).
New shingles vaccine could reduce risk of dementia – major study indicates
25 July 2024
The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine.
OH BRC Brain Technologies Theme supports world’s first epilepsy device fitted into boy’s skull
27 June 2024
A study partnership involving University of Oxford researchers from the OH BRC’s Brain Technologies Theme, Great Ormond Street Hospital, University College London and King’s College Hospital were recently involved in running a trial which led to the successful implementation of the world’s first epilepsy device fitted into the skull of a 12-year-old boy.
Professor Rachel Upthegrove made MBE
17 June 2024
Professor Rachel Upthegrove, who joins the Department of Psychiatry in August, has been made an MBE in the King’s Birthday Honours List.
Statin use among people with depression associated with lower mortality
30 May 2024
New study of more than one million people with depression in England shows that statin use is associated with lower mortality and no increased adverse events.
Is there a link between short sleep duration in childhood and the development of psychosis in young adulthood?
28 May 2024
The Mental Health Mission Midlands Translational Centre (MHMTC) is one of two demonstrator sites for the NIHR/OLS Mental Health Mission whose aim is to accelerate regional mental health research capacity and re-engage industry in both Early Psychosis (EP) and difficult to treat depression (DTD) within the context of a young, superdiverse, deprived population.
New optically pumped magnetometers (OPM) coming to Oxford
16 May 2024
The Oxford Centre for Human Brain Activity, led by Prof. Mark Woolrich, has been granted a cutting-edge piece of neuroimaging equipment – the Optically Pumped Magnetometers (OPMs).
AI to help personalise treatment for depression as part of major trial
13 May 2024
People with depression are being invited to be part of a clinical trial testing a new evidence-based AI treatment tool to personalise antidepressant treatment.